Who owns science? Who funds science?
Grim realities that will have to be confronted as the “IP waiver” proposal, put forward by India and South Africa, gets discussed at the highest level at the World Trade Organization.
In this week's episode of the pulse podcast, Leena Menghaney, South Asia Head, MSF (Médecins Sans Frontières) Access Campaign, helps breakdown the complex maze of intellectual property rights (IPR), funding of research, and the final impact on access to medicines, vaccines, diagnostics, and other medical tools, during the pandemic and beyond.
Listen in.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.